- TWD2.62bn
- TWD2.02bn
- TWD153.56m
- 28
- 13
- 36
- 11
Annual balance sheet for Phytohealth, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 759 | 1,415 | 1,361 | 1,266 | 1,080 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 14.1 | 20.4 | 25.6 | 36.1 | 40.6 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 962 | 1,618 | 1,568 | 1,499 | 1,306 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 263 | 307 | 275 | 246 | 214 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 1,810 | 2,470 | 2,365 | 2,351 | 2,440 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 77.4 | 56.2 | 62.1 | 57.4 | 54.4 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 526 | 489 | 457 | 423 | 538 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 1,284 | 1,981 | 1,908 | 1,927 | 1,901 |
Total Liabilities & Shareholders' Equity | 1,810 | 2,470 | 2,365 | 2,351 | 2,440 |
Total Common Shares Outstanding |